# EDGAR Filing Document

**Accession Number:** 0001184180
**File Stem:** 0001184180-25-000006
**Filing Date:** 2025-10
**Character Count:** 7887
**Document Hash:** 334d1075bea2e73ef998ab6d9b4ac687
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001184180-25-000006.hdr.sgml**: 20251031

**ACCESSION NUMBER**: 0001184180-25-000006

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251029

**FILED AS OF DATE**: 20251031

**DATE AS OF CHANGE**: 20251031

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** BOUSBIB ARI
- **CENTRAL INDEX KEY:** 0001184180

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35907
- **FILM NUMBER:** 251441307

**MAIL ADDRESS:**
- **STREET 1:** UNITED TECHNOLOGIES CORP
- **STREET 2:** ONE FINANCIAL PLAZA
- **CITY:** HARTFORD
- **STATE:** CT
- **ZIP:** 06101
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IQVIA HOLDINGS INC.
- **CENTRAL INDEX KEY:** 0001478242
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 271341991
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2400 ELLIS ROAD
- **CITY:** DURHAM
- **STATE:** NC
- **ZIP:** 27703
- **BUSINESS PHONE:** 919-998-2000

**MAIL ADDRESS:**
- **STREET 1:** 2400 ELLIS ROAD
- **CITY:** DURHAM
- **STATE:** NC
- **ZIP:** 27703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Quintiles IMS Holdings, Inc.
- **DATE OF NAME CHANGE:** 20161003

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Quintiles Transnational Holdings Inc.
- **DATE OF NAME CHANGE:** 20091208

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>BOUSBIB ARI<br><sub>(Last) (First) (Middle)</sub><br>C/O IQVIA HOLDINGS INC.<br>2400 ELLIS ROAD<br><sub>(Street)</sub><br>DURHAM, NC 27703<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-10-29 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_See Remarks_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>IQVIA HOLDINGS INC. [ IQV ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-10-29 |  | M |  | 77592<sup>(1)</sup> | A | $59.90 | 884755 | D |  |
| Common Stock | 2025-10-29 |  | S |  | 800<sup>(1)</sup> | D | 217.58<sup>(2)</sup> | 883955 | D |  |
| Common Stock | 2025-10-29 |  | S |  | 7315<sup>(1)</sup> | D | 218.32<sup>(3)</sup> | 876640 | D |  |
| Common Stock | 2025-10-29 |  | S |  | 13741<sup>(1)</sup> | D | 219.29<sup>(4)</sup> | 862899 | D |  |
| Common Stock | 2025-10-29 |  | S |  | 4600<sup>(1)</sup> | D | 220.11<sup>(5)</sup> | 858299 | D |  |
| Common Stock | 2025-10-29 |  | S |  | 26128<sup>(1)</sup> | D | 221.31<sup>(6)</sup> | 832171 | D |  |
| Common Stock | 2025-10-29 |  | S |  | 3973<sup>(1)</sup> | D | 221.97<sup>(7)</sup> | 828198 | D |  |
| Common Stock | 2025-10-29 |  | D |  | 21035<sup>(1)</sup> | D | $220.96 | 807163 | D |  |
| Common Stock |  |  |  |  |  |  |  | 543302 | I | By Trust<sup>(8)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Appreciation Right | $59.90 | 2025-10-29 |  | M |  |  | 77592 | 2020-02-02 | 2026-02-02 | Common Stock | 77592 | $59.90 | 50000 | D |  |

---

### Footnotes:

(1) Represents the exercise of stock appreciation rights expiring on February  2, 2026.

(2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.70 to $217.70, inclusive.

(3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.73 to $218.70, inclusive.

(4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.73 to $219.66, inclusive.

(5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.74 to $220.62, inclusive.

(6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.77 to $221.72, inclusive.

(7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.82 to $222.27, inclusive.

(8) Shares held in Orohena Trust.

**Remarks:**
Chairman, Chief Executive Officer & President

**Signature:** /s/ Matthew Gilmartin, Attorney-in-Fact for Ari Bousbib  
**Date:** 2025-10-31

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**